Please ensure Javascript is enabled for purposes of website accessibility

Foolish Weekly Fund Wrap-Up

By Amanda Kish, CFA, CFP® – Updated Nov 15, 2016 at 12:09AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bear-market ETFs are suddenly red hot.

Welcome to our seventh weekly fund review, in which we review the past week's notable fund news and tell you what it means for Foolish investors.

ProShares benefits from investor jitters
Apparently, investors are getting nervous about a potential market downturn, and bear-market ETFs are reaping the benefit. Assets at exchange-traded fund provider ProShares have grown feverishly over the past year. After entering the ETF market last June, the firm now boasts almost $6 billion in net assets. ProShares currently offers 52 different ETFs, roughly half of which short the market. These ETFs, including the UltraShort QQQ ETF (AMEX:QID) and the UltraShort S&P 500 ETF (AMEX:SDS), are designed to produce positive returns when the market falls. In recent weeks, these funds have seen a marked increase in inflows and in trading volume, as investors increasingly worry about an imminent market downturn

With a market correction likely near, it may be tempting to invest in one of these bear-market ETFs. An UltraShort ETF could potentially hedge against existing long positions in the market. But it's nearly impossible to be a successful market-timer, and trying to exactly predict a downturn is a losing battle. Investors should instead consider shifting their portfolio from recently high-performing areas into relatively lagging sectors. Remember, the market rises far more often than it falls, which means that these funds will do just the opposite.

Fidelity launches Income Replacement Funds
Fidelity plans to launch 11 funds that will convert investors' assets into regular payments. These funds will seek to make payments through the end of each fund's target date, ranging from 2016 to 2036. Each month, shareholders will receive the dividends from the Income Replacement Fund. If that amount falls short of the monthly payment, shares of the fund are automatically sold to meet the shortfall. Fidelity stated that these funds were created in response to increased demand for products that convert accumulated assets into a payment stream.

If your main investing concern is a required monthly payment every month, these new funds might be attractive to you. But there's no reason why anyone couldn't calculate their own required monthly payment on their own, instead of paying Fidelity to do it. However, these funds' creation suggests some degree of investor demand for such a product. If you decide this type of fund is right for you, look at the experience of the management team, the investment process, and the overall fund operations before buying in, and ensure that the fund makes strategic sense for your portfolio.

Two more ETFs you never knew you needed
In further evidence that the ETF steamroller rumbles onward, Van Eck is introducing two new exchange-traded funds focused on narrow market segments: nuclear energy and farming. The nuclear fund will invest in companies involved in uranium storage and enrichment, nuclear plant construction, and nuclear energy generation, such as Exelon (NYSE:EXC). The agriculture ETF will focus on companies involved in agriproducts, livestock, and agricultural equipment, such as Monsanto (NYSE:MON).

Why would any typical investor need direct exposure to either the nuclear or farming industries? I'm guessing the vast majority of assets these funds get will be purely speculative. People who don't know better will buy, thinking they can outperform the market by investing in such a narrow slice of it. Don't fall into this trap. Even more of these specialized ETFs will doubtlessly hit the market in coming months, and I'm betting you won't need any of them. Keep your focus broad, and remember that diversification is the key to long-term success.

Further fundtacular Foolishness:

Now that you know what's happening in the world of mutual funds, find out which funds represent compelling investments with Motley Fool Champion Funds. Start your free 30-day trial today.

Fool contributor Amanda Kish lives in Rochester, N.Y., and does not own shares of any of the companies or funds mentioned herein. The Fool has a disclosure policy.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Exelon Corporation Stock Quote
Exelon Corporation
EXC
$40.58 (-2.62%) $-1.09
Monsanto Company Stock Quote
Monsanto Company
MON

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.